Vaccine
Around 2,500 volunteers have received 1st component of Russian COVID-19 vaccine : Gamaleya
Moscow/Sputnik: Around 2,500 volunteers have received the first component of Russia's COVID-19 vaccine during the post-registration trials, and no significant complications have been registered, the head of the Gamaleya Research Institute of Epidemiology and Microbiology said on Tuesday.
On August 11, Russia became the first country in the world to register a vaccine against COVID-19. The vaccine, dubbed Sputnik V, was developed by the Gamaleya Institute.
"Around 2,500 Moscow residents have received the first component of the vaccine. We have not recorded any complications, apart from some minor ones, which are described in the manual," Alexander Gintsburg said at a roundtable on COVID-19.
As many as 40,000 volunteers are taking part in Phase 3 of the clinical trials, Gintsburg specified.
"The trial batches of Gamaleya's COVID-19 vaccine have been delivered to all the regions in Russia," Gintsburg told Sputnik.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
